Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article by on X, adding:
“Targeting HER2-low gastric cancer at ESMO Open.
- Clinicopathological differences
- Available studies and ongoing trials
- Action mechanisms
- IHC criteria different from breast cancer.“
HER2-low gastric cancer: is the subgroup targetable
Authors:

Source: Erman Akkus/X